Literature DB >> 9350748

Frequency and natural history of rhinovirus infections in adults during autumn.

E Arruda1, A Pitkäranta, T J Witek, C A Doyle, F G Hayden.   

Abstract

Human rhinovirus (HRV) accounts for a significant portion of common-cold illness, with the peak incidence being in the early fall. Three hundred forty-six adults who had self-diagnosed colds of 48 h or less were enrolled in a study during September and October 1994 to determine the frequency and clinical course of HRV infections. Nasal wash specimens for viral culture and reverse transcription-PCR (RT-PCR) for HRV RNA and human coronavirus OC43 and 229E RNA detection were collected on enrollment, and participants recorded their symptoms twice daily for 14 days. Middle ear pressure (MEP) was measured with a digital tympanometer on days 1 and 7. Picornaviruses (224 HRV and 7 enterovirus isolates) were detected by culture in 67% (231 of 346) of the subjects. Among 114 samples negative by culture, HRV was detected by RT-PCR in 52 (46%) for an overall picornavirus infection rate of 82% (283 of 346 subjects). Among the remaining 62 negative samples, human coronavirus RNA was detected by RT-PCR in 5 patients, so that 288 (83%) of patients had documented viral infection. The first symptom noticed most often was sore throat (40%) in HRV culture- or PCR-positive patients and stuffy nose in HRV-negative patients (27%). No differences in symptom scores over time or in the presence of individual symptoms were noted between groups. The median duration of the cold episodes was 11 days in HRV culture-positive patients, 9.5 days in HRV RT-PCR-positive patients, and 11.5 days in HRV-negative patients. On enrollment, abnormal MEPs (< or = -100 or > or = +100 mm of H2O) were found for 21% of HRV culture-positive patients, 14% of HRV RT-PCR-positive patients, and 10% of HRV-negative patients. No important differences in the clinical course of HRV culture-positive, HRV culture-negative and RT-PCR-positive, or HRV-negative colds were found. These results represent the highest frequency of virologically confirmed natural colds to date and document the importance of rhinoviruses as the cause of colds during fall months.

Entities:  

Mesh:

Year:  1997        PMID: 9350748      PMCID: PMC230076          DOI: 10.1128/jcm.35.11.2864-2868.1997

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Detection of rhinovirus in sinus brushings of patients with acute community-acquired sinusitis by reverse transcription-PCR.

Authors:  A Pitkäranta; E Arruda; H Malmberg; F G Hayden
Journal:  J Clin Microbiol       Date:  1997-07       Impact factor: 5.948

2.  Polymerase chain reaction for human picornaviruses.

Authors:  T Hyypiä; P Auvinen; M Maaronen
Journal:  J Gen Virol       Date:  1989-12       Impact factor: 3.891

3.  Rhinovirus infections in an industrial population. I. The occurrence of illness.

Authors:  J M Gwaltney; J O Hendley; G Simon; W S Jordan
Journal:  N Engl J Med       Date:  1966-12-08       Impact factor: 91.245

4.  Intranasal recombinant alfa-2b interferon treatment of naturally occurring common colds.

Authors:  F G Hayden; D L Kaiser; J K Albrecht
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

5.  Middle ear abnormalities during natural rhinovirus colds in adults.

Authors:  A Elkhatieb; G Hipskind; D Woerner; F G Hayden
Journal:  J Infect Dis       Date:  1993-09       Impact factor: 5.226

6.  Alterations of the eustachian tube, middle ear, and nose in rhinovirus infection.

Authors:  T P McBride; W J Doyle; F G Hayden; J M Gwaltney
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-09

7.  Use of polymerase chain reaction for diagnosis of picornavirus infection in subjects with and without respiratory symptoms.

Authors:  S L Johnston; G Sanderson; P K Pattemore; S Smith; P G Bardin; C B Bruce; P R Lambden; D A Tyrrell; S T Holgate
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

8.  Respiratory viruses and exacerbations of asthma in adults.

Authors:  K G Nicholson; J Kent; D C Ireland
Journal:  BMJ       Date:  1993-10-16

9.  Characterization of a nucleic acid probe for the diagnosis of human coronavirus 229E infections.

Authors:  S Myint; D Harmsen; T Raabe; S G Siddell
Journal:  J Med Virol       Date:  1990-06       Impact factor: 2.327

10.  Improved detection of rhinoviruses in nasal and throat swabs by seminested RT-PCR.

Authors:  D C Ireland; J Kent; K G Nicholson
Journal:  J Med Virol       Date:  1993-06       Impact factor: 2.327

View more
  113 in total

1.  Pharmacokinetics and safety of an antirhinoviral agent, ruprintrivir, in healthy volunteers.

Authors:  Poe-Hirr Hsyu; Yazdi K Pithavala; Merril Gersten; Carol A Penning; Bradley M Kerr
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

Review 2.  Exercise, immune function and respiratory infection: An update on the influence of training and environmental stress.

Authors:  Neil P Walsh; Samuel J Oliver
Journal:  Immunol Cell Biol       Date:  2015-11-13       Impact factor: 5.126

3.  Detection of rhinoviruses by tissue culture and two independent amplification techniques, nucleic acid sequence-based amplification and reverse transcription-PCR, in children with acute respiratory infections during a winter season.

Authors:  K Loens; H Goossens; C de Laat; H Foolen; P Oudshoorn; S Pattyn; P Sillekens; M Ieven
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

4.  Constructing the effect of alternative intervention strategies on historic epidemics.

Authors:  A R Cook; G J Gibson; T R Gottwald; C A Gilligan
Journal:  J R Soc Interface       Date:  2008-10-06       Impact factor: 4.118

5.  Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.

Authors:  Chris Mello; Esmeralda Aguayo; Madeleine Rodriguez; Gary Lee; Robert Jordan; Tomas Cihlar; Gabriel Birkus
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

6.  Improved detection of rhinoviruses in clinical samples by using a newly developed nested reverse transcription-PCR assay.

Authors:  A C Andeweg; T M Bestebroer; M Huybreghs; T G Kimman; J C de Jong
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

Review 7.  Vaccines for the common cold.

Authors:  Daniel Simancas-Racines; Juan Va Franco; Claudia V Guerra; Maria L Felix; Ricardo Hidalgo; Maria José Martinez-Zapata
Journal:  Cochrane Database Syst Rev       Date:  2017-05-18

8.  Biochemical and genetic studies of the initiation of human rhinovirus 2 RNA replication: purification and enzymatic analysis of the RNA-dependent RNA polymerase 3D(pol).

Authors:  K Gerber; E Wimmer; A V Paul
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Comparison of results of detection of rhinovirus by PCR and viral culture in human nasal wash specimens from subjects with and without clinical symptoms of respiratory illness.

Authors:  Peter F Wright; Anne M Deatly; Ruth A Karron; Robert B Belshe; Jian R Shi; William C Gruber; Yuwei Zhu; Valerie B Randolph
Journal:  J Clin Microbiol       Date:  2007-05-02       Impact factor: 5.948

10.  Rhinoviruses are a major cause of wheezing and hospitalization in children less than 2 years of age.

Authors:  Zofia Piotrowska; Marietta Vázquez; Eugene D Shapiro; Carla Weibel; David Ferguson; Marie L Landry; Jeffrey S Kahn
Journal:  Pediatr Infect Dis J       Date:  2009-01       Impact factor: 2.129

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.